Carvidon-MT Tablet ER
Marketer
Micro Labs Ltd
Salt Composition
Trimetazidine (35mg) + Metoprolol Succinate (23.75mg)
Overview Carvidon-MT Tablet ER
Extended-release Carvidon-MT tablets are a combined medication for managing angina pectoris (chest pain of cardiac origin). This medication acts to prevent angina episodes but won't alleviate an attack already in progress. It may be prescribed alone or in conjunction with other therapies. Consistent daily use, as directed by your physician, is crucial. Take it with or without food, maintaining a consistent schedule. Dosage frequency is determined by your doctor and may be adjusted based on treatment efficacy. Continuous use, even during symptom-free periods, maximizes preventative benefits and reduces the risk of future cardiac events. Discontinuing treatment may lead to angina recurrence. Adopting a heart-healthy lifestyle, including smoking cessation, moderate alcohol consumption, a balanced diet, regular physical activity, and stress management, further enhances cardiovascular well-being. Potential side effects include, but aren't limited to: lightheadedness, headache, stomach upset, diarrhea, dyspepsia, queasiness, emesis, skin rash, pruritus, urticaria, and fatigue. Report persistent or bothersome side effects to your doctor. This medication may not be appropriate for all individuals. Pre-existing liver or kidney conditions, pregnancy, breastfeeding, and all other current medications should be disclosed to your physician before commencing treatment.
Uses of Carvidon-MT Tablet ER
Chest pain stemming from heart disease (angina)
Major Benefits of Carvidon-MT Tablet ER:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Carvidon-MT Extended-Release tablet whole; avoid crushing, chewing, or breaking it. While this medication can be administered with or without food, consistency in timing is recommended.
Common Side effects of Carvidon-MT Tablet ER:
- Dizziness
- Headache
- Nausea
- Vomiting
- Weakness
- Abdominal pain
- Indigestion
- Itching
- Diarrhea
- Hives
- Slow heart rate
- Breathlessness
How to use Carvidon-MT Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Carvidon-MT Extended-Release Tablets can be administered with or without food, however, consistent timing is recommended.
How Carvidon-MT Tablet ER works:
Carvidon-MT Extended-Release tablets contain trimetazidine and metoprolol succinate. Trimetazidine supports the heart muscle's energy production, safeguarding it from oxygen deprivation. Metoprolol succinate reduces heart rate and improves the heart's pumping efficiency.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Carvidon-MT Tablet ER may pose unknown safety risks. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Data on Carvidon-MT Tablet ER use in pregnancy is absent. Seek medical advice from your physician.
Breast feedingCONSULT YOUR DOCTOR
Data on Carvidon-MT extended-release tablets and breastfeeding are currently unavailable. Seek medical advice from your physician.
DrivingCONSULT YOUR DOCTOR
The effect of Carvidon-MT Tablet ER on driving ability is undetermined. Refrain from driving if experiencing symptoms impairing concentration or reaction time.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding Carvidon-MT Tablet ER use in patients exhibiting renal impairment. Physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding Carvidon-MT Tablet ER use in individuals with hepatic impairment. Physician consultation is advised.
What if you forget to take Carvidon-MT Tablet ER :
Should you forget a Carvidon-MT Tablet ER dose, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing pattern. Avoid taking a double dose.
Facts to Know About Carvidon-MT Tablet ER
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Heart |




